Predictions
Invitae Corp
Start price
Target price
Perf. (%)
€20.09
09.11.21
09.11.21
€17.00
31.12.23
31.12.23
-23.92%
01.12.21
01.12.21
Could be very worthwhile Investment >20% year
Medpace Holdings Inc
Start price
Target price
Perf. (%)
€91.00
24.09.20
24.09.20
€145.00
04.11.21
04.11.21
114.29%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Repligen Corp.
Start price
Target price
Perf. (%)
€87.50
12.01.20
12.01.20
€155.00
04.11.21
04.11.21
170.06%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Horizon Pharma plc
Start price
Target price
Perf. (%)
€24.60
26.08.19
26.08.19
€69.00
04.11.21
04.11.21
284.63%
05.11.21
05.11.21
Immunomedics Inc.
Start price
Target price
Perf. (%)
€17.42
31.03.19
31.03.19
€22.55
04.11.21
04.11.21
326.29%
05.11.21
05.11.21
Syneos Health, Inc.
Start price
Target price
Perf. (%)
€45.18
29.03.19
29.03.19
€55.00
04.11.21
04.11.21
99.20%
05.11.21
05.11.21
Acceleron Pharma Inc.
Start price
Target price
Perf. (%)
€42.31
05.03.19
05.03.19
€120.00
04.11.21
04.11.21
254.54%
05.11.21
05.11.21
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€112.52
19.01.18
19.01.18
€140.00
04.11.21
04.11.21
42.01%
05.11.21
05.11.21
GW Pharmaceuticals plc ADR
Start price
Target price
Perf. (%)
€80.50
24.03.20
24.03.20
€180.00
04.11.21
04.11.21
127.33%
24.06.21
24.06.21
Aphria Inc.
Start price
Target price
Perf. (%)
€13.38
08.03.21
08.03.21
€15.00
13.62%
10.03.21
10.03.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€5.20
07.11.20
07.11.20
€6.40
23.49%
30.11.20
30.11.20
Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
Acceleron Pharma Inc.
Start price
Target price
Perf. (%)
€42.18
31.03.19
31.03.19
€45.10
12.09.20
12.09.20
82.54%
12.09.20
12.09.20
MorphoSys AG
Start price
Target price
Perf. (%)
€94.00
02.02.19
02.02.19
€103.00
23.07.19
23.07.19
10.00%
23.07.19
23.07.19
Could be worthwhile Investment >10% per year
Repligen Corp.
Start price
Target price
Perf. (%)
€59.62
26.04.19
26.04.19
€63.14
11.06.19
11.06.19
12.47%
11.06.19
11.06.19
Could be worthwhile Investment >10% per year
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€56.64
05.05.19
05.05.19
€69.45
11.06.19
11.06.19
55.44%
11.06.19
11.06.19
Global Blood Therapeutics Inc
Start price
Target price
Perf. (%)
€45.09
08.02.19
08.02.19
€49.61
11.06.19
11.06.19
11.93%
11.06.19
11.06.19
Blueprint Medicines Corp
Start price
Target price
Perf. (%)
€76.30
26.05.19
26.05.19
€79.38
06.06.19
06.06.19
4.18%
06.06.19
06.06.19
Ascendis Ph.sp.adr 1 Dk 1
Start price
Target price
Perf. (%)
€105.89
31.03.19
31.03.19
€117.26
28.05.19
28.05.19
10.98%
28.05.19
28.05.19
Could be worthwhile Investment >10% per year
Syneos Health, Inc.
Start price
Target price
Perf. (%)
€40.54
17.03.19
17.03.19
€45.00
29.03.19
29.03.19
13.22%
29.03.19
29.03.19
Aphria Inc.
Start price
Target price
Perf. (%)
€6.14
24.01.19
24.01.19
€10.00
05.02.19
05.02.19
63.36%
05.02.19
05.02.19
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected